Ascentage Pharma Group International SEC filings AAPG
Ascentage Pharma Group International has 132 filings in SEC EDGAR's recent list, going back to Jun 14, 2024. Its latest annual report, Form 20-F, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 28, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 28, 2026 | Oct 28, 2026 |
| 6-K | Current report (foreign issuer) | Oct 22, 2026 | Oct 22, 2026 |
| 6-K | Current report (foreign issuer) | Oct 21, 2026 | Oct 21, 2026 |
| 6-K | Current report (foreign issuer) | Oct 15, 2026 | Oct 15, 2026 |
| 6-K | Current report (foreign issuer) | Sep 29, 2026 | Sep 28, 2026 |
| 6-K | Current report (foreign issuer) | Sep 17, 2026 | Sep 17, 2026 |
| 6-K | Current report (foreign issuer) | Aug 20, 2026 | Aug 20, 2026 |
| 6-K | Current report (foreign issuer) | Aug 13, 2026 | Aug 13, 2026 |
| 6-K | Current report (foreign issuer) | Aug 5, 2026 | Aug 5, 2026 |
| 6-K | Current report (foreign issuer) | Aug 3, 2026 | Aug 3, 2026 |
| 6-K | Current report (foreign issuer) | Jul 27, 2026 | Jul 27, 2026 |
| 6-K | Current report (foreign issuer) | Jul 20, 2026 | Jul 20, 2026 |
| F-3ASR | Registration statement | Jul 20, 2026 | — |
| 6-K | Current report (foreign issuer) | Jul 13, 2026 | Jul 13, 2026 |
| 6-K | Current report (foreign issuer) | Jun 30, 2026 | Jun 30, 2026 |
| 3 | Initial insider ownership | Jun 29, 2026 | Jun 25, 2026 |
| 6-K | Current report (foreign issuer) | Jun 15, 2026 | Jun 15, 2026 |
| 6-K | Current report (foreign issuer) | Jun 12, 2026 | Jun 11, 2026 |
| 6-K | Current report (foreign issuer) | Jun 10, 2026 | Jun 10, 2026 |
| 6-K | Current report (foreign issuer) | Jun 1, 2026 | Jun 1, 2026 |
| 6-K | Current report (foreign issuer) | May 28, 2026 | May 28, 2026 |
| 6-K | Current report (foreign issuer) | May 28, 2026 | May 27, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 6-K | Current report (foreign issuer) | May 22, 2026 | May 22, 2026 |
| 6-K | Current report (foreign issuer) | May 13, 2026 | May 13, 2026 |
| 6-K | Current report (foreign issuer) | May 12, 2026 | May 12, 2026 |
| 6-K | Current report (foreign issuer) | May 1, 2026 | Apr 30, 2026 |
| 20-F | Annual report (foreign issuer) | Apr 29, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Apr 22, 2026 | Apr 22, 2026 |
| 4 | Insider transaction | Apr 21, 2026 | Apr 20, 2026 |
| 3 | Initial insider ownership | Apr 21, 2026 | Mar 18, 2026 |
| 3/A | Primary document | Apr 20, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | Apr 20, 2026 | Apr 20, 2026 |
| 3 | Initial insider ownership | Apr 10, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | Apr 1, 2026 | Apr 1, 2026 |
| 6-K | Current report (foreign issuer) | Mar 26, 2026 | Mar 26, 2026 |
| 3 | Initial insider ownership | Mar 23, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 23, 2026 | Mar 18, 2026 |
| 3/A | Primary document | Mar 23, 2026 | Mar 18, 2026 |
| 3/A | Primary document | Mar 23, 2026 | Mar 18, 2026 |
| 3/A | Primary document | Mar 23, 2026 | Mar 18, 2026 |
| 3/A | Primary document | Mar 23, 2026 | Mar 18, 2026 |
| 3/A | Primary document | Mar 23, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 23, 2026 | Mar 18, 2026 |
| 3/A | Primary document | Mar 23, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 23, 2026 | Mar 18, 2026 |
| 3/A | Primary document | Mar 23, 2026 | Mar 18, 2026 |
| 3/A | Primary document | Mar 23, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 19, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 19, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 19, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 19, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 19, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 19, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 19, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | Mar 18, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | Mar 16, 2026 | Mar 13, 2026 |
| 6-K | Current report (foreign issuer) | Mar 11, 2026 | Mar 11, 2026 |
| 6-K | Current report (foreign issuer) | Feb 23, 2026 | Feb 23, 2026 |
| 6-K | Current report (foreign issuer) | Feb 9, 2026 | Feb 9, 2026 |
| 6-K | Current report (foreign issuer) | Feb 6, 2026 | Feb 6, 2026 |
| 6-K | Current report (foreign issuer) | Jan 15, 2026 | Jan 15, 2026 |
| 6-K | Current report (foreign issuer) | Jan 7, 2026 | Jan 7, 2026 |
| 6-K | Current report (foreign issuer) | Dec 31, 2025 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Dec 17, 2025 | Dec 17, 2025 |
| 6-K | Current report (foreign issuer) | Dec 9, 2025 | Dec 9, 2025 |
| 6-K | Current report (foreign issuer) | Dec 8, 2025 | Dec 8, 2025 |
| 6-K | Current report (foreign issuer) | Dec 5, 2025 | Dec 5, 2025 |
| 6-K | Current report (foreign issuer) | Dec 1, 2025 | Dec 1, 2025 |
| 6-K | Current report (foreign issuer) | Nov 28, 2025 | Nov 28, 2025 |
| 6-K | Current report (foreign issuer) | Nov 25, 2025 | Nov 25, 2025 |
| 6-K | Current report (foreign issuer) | Nov 19, 2025 | Nov 19, 2025 |
| 6-K | Current report (foreign issuer) | Nov 4, 2025 | Nov 4, 2025 |
| 6-K | Current report (foreign issuer) | Oct 30, 2025 | Oct 30, 2025 |
| 6-K | Current report (foreign issuer) | Oct 7, 2025 | Oct 7, 2025 |
| S-8 | Employee stock plan registration | Sep 16, 2025 | — |
| S-8 POS | Post-effective amendment no. 1 to form s-8 | Aug 28, 2025 | — |
| 6-K | Current report (foreign issuer) | Aug 28, 2025 | Aug 25, 2025 |
| 6-K | Current report (foreign issuer) | Aug 21, 2025 | Aug 21, 2025 |
| 6-K | Current report (foreign issuer) | Aug 18, 2025 | Aug 18, 2025 |
| 6-K | Current report (foreign issuer) | Aug 8, 2025 | Aug 8, 2025 |
| 6-K | Current report (foreign issuer) | Aug 7, 2025 | Aug 7, 2025 |
| 6-K | Current report (foreign issuer) | Aug 1, 2025 | Aug 1, 2025 |
| 6-K | Current report (foreign issuer) | Jul 25, 2025 | Jul 25, 2025 |
| 6-K | Current report (foreign issuer) | Jul 17, 2025 | Jul 17, 2025 |
| 6-K | Current report (foreign issuer) | Jul 15, 2025 | Jul 14, 2025 |
| 6-K | Current report (foreign issuer) | Jul 10, 2025 | Jul 10, 2025 |
| 6-K | Current report (foreign issuer) | Jul 8, 2025 | Jul 8, 2025 |
| 6-K | Current report (foreign issuer) | Jun 27, 2025 | Jun 27, 2025 |
| 6-K | Current report (foreign issuer) | Jun 16, 2025 | Jun 16, 2025 |
| 6-K | Current report (foreign issuer) | Jun 10, 2025 | Jun 9, 2025 |
| 6-K | Current report (foreign issuer) | Jun 3, 2025 | Jun 3, 2025 |
| 6-K | Current report (foreign issuer) | May 23, 2025 | May 23, 2025 |
| 6-K | Current report (foreign issuer) | May 20, 2025 | May 19, 2025 |
| 6-K | Current report (foreign issuer) | Apr 28, 2025 | Apr 28, 2025 |
| 6-K/A | Amendment no. 1 to form 6-k | Apr 24, 2025 | Apr 24, 2025 |
| 6-K | Current report (foreign issuer) | Apr 21, 2025 | Apr 21, 2025 |
| 6-K | Current report (foreign issuer) | Apr 17, 2025 | Apr 16, 2025 |
| 20-F | Annual report (foreign issuer) | Apr 16, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Apr 8, 2025 | Apr 8, 2025 |
| 6-K | Current report (foreign issuer) | Mar 31, 2025 | Mar 31, 2025 |
| 6-K | Current report (foreign issuer) | Mar 27, 2025 | Mar 27, 2025 |
| 6-K/A | Amendment no. 1 to form 6-k | Mar 26, 2025 | Mar 26, 2025 |
| 6-K | Current report (foreign issuer) | Mar 26, 2025 | Mar 25, 2025 |
| 6-K | Current report (foreign issuer) | Mar 12, 2025 | Mar 12, 2025 |
| 6-K | Current report (foreign issuer) | Mar 6, 2025 | Mar 5, 2025 |
| 6-K | Current report (foreign issuer) | Feb 25, 2025 | Feb 25, 2025 |
| 6-K | Current report (foreign issuer) | Feb 14, 2025 | Feb 13, 2025 |
| 6-K | Current report (foreign issuer) | Feb 11, 2025 | Feb 7, 2025 |
| SEC STAFF LETTER | Filing | Jan 24, 2025 | — |
| 424B4 | Prospectus | Jan 24, 2025 | — |
| S-8 | Employee stock plan registration | Jan 24, 2025 | — |
| EFFECT | Filing | Jan 23, 2025 | — |
| CERT | Filing | Jan 23, 2025 | — |
| 8-A12B | Filing | Jan 21, 2025 | — |
| CORRESP | Letter to the SEC | Jan 21, 2025 | — |
| CORRESP | Letter to the SEC | Jan 21, 2025 | — |
| F-1/A | Filing | Jan 21, 2025 | — |
| F-1 | Registration statement (foreign issuer) | Dec 27, 2024 | — |
| SEC STAFF LETTER | Filing | Dec 17, 2024 | — |
| DRS/A | Filing | Dec 10, 2024 | — |
| DRS/A | Filing | Sep 16, 2024 | — |
| DRSLTR | Filing | Sep 13, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2024 | — |
| DRSLTR | Filing | Aug 27, 2024 | — |
| DRS/A | Filing | Aug 27, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 15, 2024 | — |
| DRSLTR | Filing | Jul 31, 2024 | — |
| DRS/A | Filing | Jul 31, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 12, 2024 | — |
| DRS | Filing | Jun 14, 2024 | — |
Showing 132 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AAPG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Suzhou , Jiangsu
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 2023311
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.